PREPARATION OF NONCRYSTALLINE CALCIUM ATORVASTATIN Russian patent published in 2008 - IPC C07D207/34 

Abstract RU 2324679 C2

FIELD: technological processes.

SUBSTANCE: method of atorvastatin preparation in noncrystalline form includes: a) preparation of solution that contains intermediate compound of the following formula (I) in nonhydroxyl dissolvant: , where A stands for generic protective group or separate protective groups for dihydroxygroup, and B stands for protective group for carboxyl group; b) removal of protection from dihydroxygroup; c) removal of protection from carboxyl group; at that sequence of stages b) and c) may be reverse; d) solution concentration approximately to half or less of initial volume; e) addition of water volume, which is excessive in comparison with volume of concentrated solution; f) addition of dissolvent that poorly mixes or does not mix with water and in which calcium atorvastatin does not dissolve or dissolves poorly, and the volume of this dissolvent is approximately equal to or more than water volume that was added to stage e); g) optional operation of mixing and division into two phases; h) neutralization of water phase; i) conversion of atorvastatin in the form of dihydroxycarboxylic acid into pharmaceutically acceptable form of salt; and j) creation of calcium atorvastatin deposit, which is obtained by conversion to mentioned pharmaceutically acceptable form of salt.

EFFECT: improves stages of calcium atorvastatin preparation out of atorvastatin lactone form.

22 cl, 1 dwg, 2 ex

Similar patents RU2324679C2

Title Year Author Number
FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES 2002
  • Suri Sandzhaj
  • Singkh Dzhudzhkhar
  • Greval Manmokhan Singkh
  • Radzh Baldev
RU2294924C2
STABLE ATORVASTATIN COMPOSITIONS OBTAINED BY HUMID GRANULATION 2004
  • Uoterman Kennet Krejg
  • Ferdzhione Majkl Brjus
  • Dzhonson Barbara Ehlis
RU2332211C2
CRYSTALLINE FORMS OF [R[(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROL-1-HEPTANOIC ACID 2004
  • Kehmpeta Ehntoni Majkl
  • Krzhizanjak Dzhozef Frehnsis
  • Leonard Dzhejson Al'Bert
RU2315755C2
CRYSTALLINE FORMS VI AND VII OF ATORVASTATIN CALCIUM SALT 2002
  • Reddi M. Sat'Janarajana
  • Nagaradzhu Chakilam
  • Srinivasulu Gudipati
  • Sinivas Katakam
  • Reddi Sadzhijam Radzhesvar
RU2304139C2
PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN PREPARED WITHOUT GRANULATION 2004
  • Berkielli Al'Fred
  • Uoterman Kennet Krejg
  • Doehriti Patrik Dehvid
RU2314804C2
METHOD OF AMORPHOUS CALCIUM ATORVASTATIN OBTAINING 2005
  • Rouz Piter Robert
  • Leonard Dzhejson Al'Bert
RU2330840C1
NEW CRYSTALLINE STRUCTURES (POLYMORPHIC MODIFICATIONS) SEMICALCIUM SALT OF ATORVASTATIN AND METHODS OF OBTAINING OF THESE AND OTHER POLYMORPHIC MODIFICATIONS OF SALT OF ATORVASTATIN 2001
  • Aronkhajm Dzhudit
  • Lidor-Khadas Remi
  • Niddam-Khildishejm Valeri
  • Kovalevski-Ishaj Ehti
  • Livshits-Liron Rivajtl
  • Samburski Gaj
RU2344127C2
METHOD OF PRODUCTION OF MEVALONIC ACID DERIVATIVES INHIBITING HMG-COA REDUCTASE 2003
  • Zedel'Majer Gottfrid
  • Mates Kristian
RU2335500C2
PHARMACEUTICAL FORMULATION OF ATORVASTATIN 2004
  • Uoterman Kennet Krejg
  • Luner Pol Ehvan
RU2325903C2
RENNIN INHIBITOR SYNTHESIS WITH USING CYCLOADDITION REACTION 2006
  • Mikel St'Juart Dzhon
  • Marterer Vol'Fgang
RU2423348C2

RU 2 324 679 C2

Authors

Sorsak Gorazd

Dates

2008-05-20Published

2002-01-22Filed